Allopurinol CAS 315-30-0

Allopurinol CAS 315-30-0

Identification

CAS Number

315-30-0

Name

Allopurinol

Synonyms

1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-on [German] [ACD/IUPAC Name]
1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one [ACD/IUPAC Name]
1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one [French] [ACD/IUPAC Name]
1H-Pyrazolo(3,4-d)pyrimidin-4-ol
2,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
206-250-9 [EINECS]
315-30-0 [RN]
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-, radical ion(1+)
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,7-dihydro- [ACD/Index Name]
691008-24-9 [RN]
7H-Pyrazolo[3,4-d]pyrimidin-4-ol
Adenock [Trade name]
Allopurin [Trade name]
Allopurinol [BAN] [INN] [JAN] [USAN] [Wiki]
Allopurinolum [Latin] [INN]
Alopurinol [Spanish] [INN]
Anoprolin [Trade name]
Bleminol [Trade name]
Caplenal [Trade name]
Cellidrin [Trade name]
Epidropal [Trade name]
Foligan [Trade name]
Hexanurat [Trade name]
Hexanuret
HPP
Isopurinol
MFCD00599413 [MDL number]
Remid [Trade name]
Sigapurol
T56 BMN GN INJ FQ [WLN]
Takanarumin [Trade name]
Urosin [Trade name]
Zyloprim [Trade name]
Zyloric [Trade name]
аллопуринол [Russian]
ألوبيرينول [Arabic]
别嘌醇 [Chinese]
7HP
Apo-Allopurinol
Uritas
[315-30-0] [RN]
1(2),5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one
1-(2-Allyl-phenoxy)-3-isopropylamino-propan-2-ol
1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
1,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one
1,5Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one Synonym: Allopurinol
1,5-Dihydropyrazolo[3,4-d]pyrimidin-4-one
1,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-one
1,7-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE
1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one
1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one
1H,4H,7H-pyrazolo[3,4-d]pyrimidin-4-one
1h-pyrazolo (3 4 -d)pyrimidin-4-ol
1H-pyrazolo[3,4-d]pyrimidin-4(2H)-one
1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one
1H-pyrazolo[3,4-d]pyrimidin-4(7H)-one
1H-pyrazolo3,4-dpyrimidin-4-ol
2-(dihydroxymethyl)-2,5-dihydrofuran-2,5-diol
291279-53-3 [RN]
2H-pyrazolo[3,4-d]pyrimidin-4(5H)-one
2H-pyrazolo[3,4-d]pyrimidin-4(7H)-one
2H-Pyrazolo[3,4-d]pyrimidin-4-ol (9CI)
4-HPP
4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,5-dihydro- (9CI)
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,7-dihydro- (9CI)
4h-pyrazolo[3,4-d]pyrimidin-4-one,1,2-dihydro-
4h-pyrazolo[3,4-d]pyrimidin-4-one,1,7-dihydro-
4h-pyrazolo[3,4-d]pyrimidin-4-one,2,5-dihydro-
4h-pyrazolo[3,4-d]pyrimidin-4-one,2,7-dihydro-
4-Hydroxy-1H-pyrazolo[3,4-d]pyrimidine
4-Hydroxy-3,4-pyrazolopyrimidine
4-Hydroxypyrazol[3,4-D]pyrimidine
4-Hydroxypyrazole[3,4-d]pyrimidine
4-Hydroxypyrazolyl[3,4-d]pyrimidine
4-Oxopyrazolo[3,4-d]pyrimidine
916979-34-5 [RN]
Ailural
Ailurial
ALLO
Allohexal
Allohexan
Alloinol
Alloprin
Allopur
ALLOPURINOL[3H]
Allopurinol-d2
Alloril
Allorin
Allosig
Allozym
Allpargin
Allural
Aloprim
Aloprim
Alopurinol
Aloral
Alositol
Aluline
Aluron
Anzief
Apulonga
Apurin
Apurol
Atisuril
Bloxanth
BW 56-158
BW-56-158
Capurate
cid_2094
Cosuric
Dabrosin
Dabroson
DB00437
Dura Al
Embarin
Epuric
Geapur
Gichtex
Gotax
Jenapurinol
Ketanrift
Ketobun-A
Ledopur
Lopurin
Lysuron
MFCD08234377 [MDL number]
MFCD08276167 [MDL number]
MFCD18384981
Milurit
Milurite
Miniplanor
Monarch [Wiki]
Nektrohan
Novopurol
Pan Quimica
Progout
Purinol
pyrazolo[5,4-d]pyrimidin-4-ol
Quimica, Pan
Riball
Rimapurinol
Roucol
Suspendol
Tipuric
Urbol
Uribenz
Uricemil
Uridocid
Uriprim
Uripurinol
Urobenyl
Urolit
Urtias
Urtias 100
Xanthomax
Xanturat
Xanturic
Zygout
Zyloprim
Zyloprim;HPP
Zyrik

SMILES

c1c2c(ncnc2O)n[nH]1

StdInChI

InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)

StdInChIKey

OFCNXPDARWKPPY-UHFFFAOYSA-N

Molecular Formula

C5H4N4O

Molecular Weight

136.111

EINECS

206-250-9

MDL Number

MFCD00599413

Properties

Appearance

Off-white powder


Structure

structure of Allopurinol CAS 315-30-0

structure of Allopurinol CAS 315-30-0

Safety Data

Symbol

Signal Word

Warning

WGK Germany

3

MSDS Download

Specifications and Other Information of Our

Identification Methods

HNMR, HPLC

Assay

98% min

Limit of Hydrazine

NMT 10 ppm (LOQ-0.2 ppm)
(In house Limit : NMT 2.5 ppm)

Residual solvent (By GC)

NMT 220 ppm(LOQ-50 ppm)

Organic Impurities

Allopurinol related compound A: NMT 0.20%
(In-house: NMT 0.10%) (LOQ-0.03%)
Allopurinol related compound B: NMT 0.20%
(In-house: NMT 0.10%) (LOQ-0.02%)
Allopurinol related compound C: NMT 0.20%
(In-house: NMT 0.10%) (LOQ-0.02%)
Allopurinol related compound D: NMT 0.20%
(In-house: NMT 0.10%) (LOQ-0.03%)
Alluµul’luul r匕lated cumpoun<l E: NMT 0.20%
(In-house: NMT 0.10%) (LOQ-0.04%)
‘Ethyl-(E/Z)-3(2-carbethoxy-2-cyanoethenyl)amino-1 H- pyrazole-4-carboxylate’: NMT 0.2% (LOQ-0.02%) Any individual unspecified impurity: NMT O.10%
(LOQ-0.02%)
Total impurities: NMT 1.0%

Loss on Drying

NMT 0.5 % (Dr)’1.0 gin vacuum at 105°C for 5 hours).

Shelf Life

5 years

Storage

Under room temperature away from light

Known Application

Allopurinol can help reduce the symptoms of muscle stiffness and tremors in individuals with Parkinson’s disease. By inhibiting the action of acetylcholine in the central nervous system, it helps reduce abnormal muscle.Parkinson’s disease patients often experience abnormal gait and coordination difficulties.Allopurinol can assist in improving these issues, leading to smoother and more coordinated walking.
Allopurinol is also used to treat excessive saliva secretion, which may occur in certain conditions and as a side effect of certain medications, including Parkinson’s disease.

General View of Documents

This product is sold exclusively through our sales company Watson International Limited, and please click the link below for details (https://www.watson-int.com/).